Delek stock: NewMed names Yanki Quint as chairman

Published on 11/09/2026 at 00:33 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Delek stock faces a leadership change at NewMed Energy. Yanki Quint is set to become chairman on November 1.

NewMed leadership shifts within Delek

Yaakov Quint is set to chair NewMed Energy after serving in senior Israeli public-sector roles.
Niv Sarne is moving from the chairmanship to become NewMed's general manager.
The change affects a key Delek Group energy holding linked to the Leviathan gas field.

Delek, IL0010841281, Illustration mit AI erstellt.

NewMed Energy, controlled by Delek Group, has appointed Yaakov "Yanki" Quint as chairman of its board, according to The Jerusalem Post. The announcement was made on Wednesday, October 28, and the appointment is scheduled to take effect on November 1.

New chairman takes key energy role

Quint replaces Niv Sarne, who is moving into the role of NewMed's general manager. Sarne had held the chairmanship for about two months after replacing Gaby Last, who retired from the position.

The Jerusalem Post said Quint previously served as director of the Israel Land Authority from 2020 to 2025 and as director of the Government Companies Authority from 2017 to 2020. The appointment places a former senior public-sector official at the head of one of Delek Group's most important energy holdings.

Leviathan remains central to exposure

NewMed Energy holds a 45 percent stake in the Leviathan gas field, alongside Chevron with 40 percent and Ratio Energies with 15 percent, according to The Jerusalem Post. The leadership change therefore matters primarily for Delek's upstream gas exposure and its relationship with the partnership managing the field.

Delek Group operates across energy, financial services and real estate, according to its investor relations page. Its holding-company model is broader than the focused Leviathan positions associated with Chevron and Ratio Energies, while the NewMed stake gives Delek a significant role in Israel's offshore gas sector.

Investors will next have to assess how the management transition affects NewMed's strategic direction and Delek's wider energy portfolio. Delek Group's investor relations calendar lists November 25, 2026 as the date for its next results announcement.

Israel's wider equity market can be followed through TA-35 market coverage.

More news and analyses on Delek stock.